Table 2.
Meta-analysis results of continuous outcomes
| Outcome | Meta-analysis | Heterogeneity | Certainty | ||
|---|---|---|---|---|---|
| Treatment effect (95% CI) | p-value | τ 2 | Prediction interval | ||
| Body mass index (kg/m2) | −3.58 (−4.86 to −2.3) | <0.001 | 1.00 | −5.93 to −1.24 | High |
| Body weight (kg) | −11.32 (−15.35 to −7.29) | <0.001 | 10.15 | −18.75 to −3.89 | High |
| Diastolic blood pressure (mmHg) | −0.39 (−2.83 to 2.06) | 0.756 | 0.00 | −2.83 to 2.06 | Low |
| Fasting glucose (mmol/L) | −0.54 (−0.94 to −0.13) | 0.010 | 0.09 | −1.26 to 0.19 | Moderate |
| Fasting insulin (mU/L) | −3.03 (−7.98 to 1.93) | 0.231 | 1.50 | −8.53 to 2.48 | Very low |
| Fasting triglycerides (mmol/L) | −0.14 (−0.41 to 0.13) | 0.305 | 0.00 | −0.41 to 0.13 | Very low |
| Haemoglobin A1c (%) | −0.37 (−0.51 to −0.22) | <0.001 | 0.01 | −0.62 to −0.11 | High |
| High-density lipoprotein (mmol/L) | 0.07 (−0.1 to 0.24) | 0.434 | 0.02 | −0.24 to 0.38 | Very low |
| Systolic blood pressure (mmHg) | −2.34 (−5.53 to 0.84) | 0.149 | 0.00 | −5.53 to 0.84 | Low |